{"text": ["Novo", "Nordisk's", "(NVO)", "Oral", "Ozempic", "Positive", "in", "Diabetes", "Study"], "created_at": "2018-06-21 22:08:48"}
{"text": ["Novo", "Nordisk's", "(NVO)", "Oral", "Ozempic", "Positive", "in", "Diabetes", "Study"], "created_at": "2018-06-21 22:08:48"}
{"text": ["Novo", "Nordisk", "Stock", "Rises", "4%", "Over", "2", "Sessions"], "created_at": "2018-06-21 21:33:00"}
{"text": ["Novo", "Nordisk&apos;s", "(NVO)", "Oral", "Ozempic", "Positive", "in", "Diabetes", "Study"], "created_at": "2018-06-21 19:39:07"}
{"text": ["European", "ADRs", "Move", "Lower", "in", "Thursday", "Trading"], "created_at": "2018-06-21 16:07:10"}
{"text": ["European", "ADRs", "Move", "Lower", "in", "Thursday", "Trading"], "created_at": "2018-06-21 16:07:10"}
{"text": ["Novo", "Nordisk", "Stock", "Pops", "Nearly", "3%", "on", "Positive", "Diabetes-Drug", "Results"], "created_at": "2018-06-21 13:48:00"}
{"text": ["Novo", "Nordisk", "in", "Deal", "with", "Kallyope", "for", "Obesity,", "Diabetes", "Drugs"], "created_at": "2018-06-21 00:08:01"}
{"text": ["Novo", "Nordisk", "in", "Deal", "with", "Kallyope", "for", "Obesity,", "Diabetes", "Drugs"], "created_at": "2018-06-21 00:08:01"}
